Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 27;23(1):123.
doi: 10.1186/s12944-024-02114-z.

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001-2018

Affiliations

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001-2018

Di-Yu Cui et al. Lipids Health Dis. .

Abstract

Background: The triglyceride glucose (TyG) index and triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio are recognized as simple non-insulin-based insulin resistance indices. Our study aimed to explore the relationship between these two indicators and heart failure (HF) in overweight or obesity individuals without diabetes.

Methods: This cross-sectional study selected 13,473 participants from the National Health and Nutrition Examination Survey (NHANES) 2001-2018 dataset. Weighted multivariable logistic regression and subgroup analysis were employed to evaluate the relationships between TyG index, TG/HDL-C ratio, and HF prevalence, respectively. Additionally, smooth curve fitting was utilized to analyze the dose-response relationships.

Results: A total of 13,473 obesity or overweight people without diabetes were included in this study through screening, among whom 291 (2.16%) had comorbid HF. The results of multivariable logistic regression suggested that the highest TyG index (OR = 2.4, 95% CI = 1.4-4.2, p = 0.002) and the highest TG/HDL-C ratio (OR = 1.2, 95% CI = 1.1-1.3, p < 0.001) both increased the prevalence of HF, especially in the non-Hispanic population. Dose-response relationships suggested nonlinear relationships between these two indicators and HF.

Conclusion: Our study demonstrated that elevated TyG index and TG/HDL-C ratio were closely associated with the prevalence of HF, and both exhibited nonlinear relationships with HF prevalence in overweight/obesity adults without diabetes. Based on these findings, additional prospective studies are needed for further validation.

Keywords: Heart failure; Overweight/obesity; Triglyceride-glucose index; Triglyceride-to-high-density lipoprotein cholesterol ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of participants selection from the NHANES 2001–2018
Fig. 2
Fig. 2
Subgroup analysis of the association between the prevalence of HF and TyG index (A), TG/HDL-C ratio (B). Adjusted for age, sex, ethnicity, systolic blood pressure (mmHg), diastolic blood pressure (mmHg), albumin(g/dl), creatinine (mg/dL), low density lipoprotein (mg/dl), total cholesterol (mg/dl), smoke statue, stroke and CHD, except the stratified factor itself. IFG, impaired fasting glucose; CHD, coronary heart disease; SBP, systolic blood pressure
Fig. 3
Fig. 3
Smooth curve fitting using Generalized Additive Model (GAM) to evaluate the nonlinear relationship between TyG index (A), TG/HDL-C ratio (B) and the proportion of HF. The red solid line represents the probability of HF occurrence and the blue dotted line represents the 95% CI curve

Similar articles

Cited by

References

    1. Federation WO. World Obesity Atlas 2023. https://dataworldobesityorg/publications/?cat=19 2023.
    1. Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24. - PMC - PubMed
    1. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. Circulation. 2007;116(6):627–36. - PubMed
    1. Erqou S, Adler AI, Challa AA, Fonarow GC, Echouffo-Tcheugui JB. Insulin resistance and incident heart failure: a meta-analysis. Eur J Heart Fail. 2022;24(6):1139–41. - PMC - PubMed
    1. Son TK, Toan NH, Thang N, Le Trong Tuong H, Tien HA, Thuy NH, Van Minh H, Valensi P. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension. Cardiovasc Diabetol. 2022;21(1):75. - PMC - PubMed